Haolin Shen

Haolin Shen

University of California San Francisco - San Francisco / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 5476751
person_outline Haolin Shen's MOST POPULAR ARTICLES
1-) Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics …P Horak, M Griffith, AM Danos, BA Pitel, S Madhavan, X Liu, C Chow, ...Genetics in Medicine 24 (5), 986-998, 2022902022
2-) CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebaseK Krysiak, AM Danos, J Saliba, JF McMichael, AC Coffman, S Kiwala, ...Nucleic acids research 51 (D1), D1230-D1241, 2023122023
3-) Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancerSL Freshour, THP Chen, B Fisk, H Shen, M Mosior, ZL Skidmore, ...Iscience 26 (10), 202322023
4-) Optimization of the Irf8 +32-kb enhancer disrupts dendritic cell lineage segregationF Ou, TT Liu, P Desai, ST Ferris, S Kim, H Shen, RA Ohara, S Jo, J Chen, ...Nature Immunology, 1-14, 20242024
5-) 12. Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in bladder cancerS Freshour, B Fisk, T Chen, H Shen, M Mosior, Z Skidmore, C Fronick, ...Cancer Genetics 278, 4, 20232023